Skip to main content
. Author manuscript; available in PMC: 2021 Mar 2.
Published in final edited form as: J Allergy Clin Immunol. 2020 Dec;146(6):1217–1270. doi: 10.1016/j.jaci.2020.10.003

TABLE II.

Interpretations of Feno test results for asthma diagnosis in nonsmoking individuals not taking corticosteroids*

Feno level

<25 ppb (<20 in children aged 5–12 y) 25–50 ppb (20–35 in children aged 5–12 y) >50 ppb (>35 in children aged 5–12 y)
• Recent or current corticosteroid use • Evaluate in clinical context • Eosinophilic airways inflammation likely
• Alternative diagnoses • Consider other diagnoses • Phenotype more likely to respond to ICS
• Phenotype less likely to benefit from ICS • Consider other factors influencing result • Allergic asthma
• Noneosinophilic asthma • Eosinophilic asthma less likely • Eosinophilic bronchitis
• COPD
• Bronchiectasis
• CF
• Vocal cord dysfunction
• Rhinosinusitis
• Smoking
• Obesity

CF, Cystic fibrosis; COPD, chronic obstructive pulmonary disease.

*

Reprinted with permission of the American Thoracic Society, ©2019 American Thoracic Society. Dweik RA, Boggs PB, Erzurum SC, Irvin CG, Leigh MW, Lundberg JO, et al. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FeNO) for clinical applications. Am J Respir Crit Care Med 2011;184:602–15. The American Journal of Respiratory and Critical Care Medicine is an official journal of the American Thoracic Society.